Skip to content

Clinical trials

Phase 1 Liver Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1 Country / region: South Korea Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20151
20161
20191
20201
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals1
Aptamer Sciences, Inc.1
Blueprint Medicines Corporation1
Coherus Oncology, Inc.1
Etnova Therapeutics Corp.1
H3 Biomedicine Inc.1
Jennerex Biotherapeutics1
Myeloid Therapeutics1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms9
Carcinoma, Hepatocellular8
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Liver Diseases2
Neoplasm Metastasis2
Adenocarcinoma of Lung1
Carcinoma, Renal Cell1
Kidney Neoplasms1
Lung Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.